| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.60B | 41.72B | 30.57B | 27.81B | 21.81B | 16.77B |
| Gross Profit | 26.36B | 22.47B | 17.10B | 14.77B | 11.63B | 9.14B |
| EBITDA | 12.11B | 10.93B | 8.80B | 7.73B | 6.45B | 4.89B |
| Net Income | 6.91B | 5.96B | 3.32B | 4.27B | 3.25B | 2.48B |
Balance Sheet | ||||||
| Total Assets | 156.18B | 143.02B | 122.45B | 98.57B | 62.05B | 58.26B |
| Cash, Cash Equivalents and Short-Term Investments | 30.24B | 32.18B | 14.47B | 22.78B | 13.19B | 19.90B |
| Total Debt | 52.64B | 46.89B | 37.83B | 20.40B | 17.80B | 19.45B |
| Total Liabilities | 73.76B | 64.54B | 51.76B | 34.04B | 30.89B | 30.01B |
| Stockholders Equity | 81.91B | 78.02B | 70.59B | 64.54B | 31.17B | 28.25B |
Cash Flow | ||||||
| Free Cash Flow | 8.53B | 12.57B | -910.00M | 3.24B | 3.36B | 1.79B |
| Operating Cash Flow | 9.54B | 14.69B | -17.00M | 4.06B | 3.81B | 3.18B |
| Investing Cash Flow | -4.45B | -3.47B | -24.86B | -22.77B | -8.10B | -9.08B |
| Financing Cash Flow | 1.27B | 6.48B | 16.58B | 28.30B | -2.41B | 18.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥32.96B | 16.74 | ― | 2.58% | 8.10% | 42.93% | |
70 Outperform | ¥1.09T | 18.91 | 12.15% | 1.01% | 33.50% | 17.26% | |
63 Neutral | ¥231.00B | 26.76 | ― | 0.43% | 20.55% | 48.62% | |
63 Neutral | ¥65.71B | 228.03 | ― | 0.39% | 6.17% | -8918.66% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥68.06B | 77.03 | 5.76% | ― | 31.95% | -40.95% | |
44 Neutral | ¥2.66B | -4.28 | ― | ― | 16.19% | -4.42% |